QLI News and Press, Qilian International Holding Group Ltd. From 01/19/22

Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets PR Newswire JIUQUAN, China , Jan. 19, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Compan...

Qilian International Holding Group Limited Releases 2022 Chairman Letter PR Newswire JIUQUAN, China , Jan. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China ...

Gainers: Galera Therapeutics (NASDAQ:GRTX) +11%. TFF Pharmaceuticals TFFP +7%. Annexon (NASDAQ:ANNX) +6%. Clarus Therapeutics Holdings (NASDAQ:CRXT) +4%. Tyra Biosciences (NASDAQ:TYRA) +4%. Losers: CalAmp CAMP -14%. Qilian International Holding Group  (NASDAQ:QLI) -4%...

Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province PR Newswire JIUQUAN, China ,...

Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer Prevention PR Newswire JIUQUAN, China, Nov. 15, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI ) (the "Company")...

Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic PR Newswire JIUQUAN, China, Nov. 1, 2021 /PRNewswire/ -- Qilian International Holding Group Lim...

Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production PR Newswire JIUQUAN, China , Oct. 26, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (N...

Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt PR Newswire JIUQUAN, China, Oct. 13, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharm...

Jiuquan, China, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced its unaudited financial results for the first six months of fiscal year...

Jiuquan, China, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company, through its PRC subsidiary Chengdu Qilianshan Biotechn...